Navigation Links
Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans
Date:4/21/2011

piry of the ENBREL profit share agreement with Pfizer is expected to improve the Company's adjusted operating income by $800 million each year in 2014 and 2015 compared to 2010. The Company also plans to deliver cost savings in all areas of G&A and targeted areas of commercial spend. These benefits will be partially offset by increases in the U.S. Healthcare Reform Excise Fee and the profit share on Prolia international sales.  Peacock also noted the Company's plan to invest between 18 and 20 percent of sales each year in R&D.

Peacock stated that the focus for future acquisition and licensing investments would be to advance the Company's strategy to bring innovative medicines to market and expand the company's operating footprint into emerging markets and Japan. Peacock also highlighted that the Company will be disciplined in ensuring that investments deliver both profitable growth and an attractive return on capital.

Amgen expects several growth drivers for its business beyond 2015 which include Prolia and XGEVA, several pipeline launches, expansion into emerging markets and Japan and investments to build a biosimilars portfolio.

A webcast of the Amgen Business Review meeting with presentation slides and video is available through www.amgen.com

Forward-Looking Non-GAAP Financial Measures

Management has presented herein certain forward-looking statements about the Company's future financial performance that include non-GAAP (or "as-adjusted") financial measures, including Adjusted Net Income, Adjusted Operating Margin, Adjusted Operating Income, Adjusted EPS, Adjusted Cost of Sales, Adjusted R&D and Adjusted SG&A expense. These non–GAAP financial measures are derived by excluding certain amounts, expenses or income, from the corresponding financial measures determined in accordance with U.S. Generally Accepted Accounting Principles (GAAP). The Company believes t
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
2. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
3. Amgen to Webcast 2011 Business Review Meeting on April 21
4. Amgen Announces Webcast of 2011 First Quarter Financial Results
5. Amgen Establishes Commercial Operations in Brazil
6. Amgen to Appeal CHMP Opinion on Vectibix® (Panitumumab) Use With Chemotherapy in Metastatic Colorectal Cancer in Europe
7. Amgen Donates $1 Million to Help Japanese Disaster Victims
8. Amgen Completes Acquisition of BioVex
9. NBPTS and Amgen Foundation Join to Bolster Science Education
10. Amgen to Present at the Citi 2011 Global Healthcare Conference
11. CURE Magazine Teams Up With Amgen Oncology and Breakaway from Cancer® to Launch 2011 Extraordinary Healer Award for Oncology Nursing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015  China Nepstar Chain Drugstore Ltd. (NYSE: ... drugstore chain in China based ... the resignation of Mr. Fuxiang Zhang as ... immediately. Ms. Rebecca Yingnan Zhang has been ... of directors, effective immediately. Meanwhile, Ms. Zhang resigned from ...
(Date:5/21/2015)... Research and Markets ... of the "Arthroscopy Devices Markets Worldwide" ... http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose of this report ... market for Arthroscopy Devices. The report discusses ... market for these products. , ,Product - ...
(Date:5/21/2015)... , 21. Mai 2015 ... ), ein Unternehmen für Arzneimittel im ... Entwicklung und Vermarktung von Locilex® (Pexiganan-Creme ... heute eine wissenschaftliche Posterpräsentation an, welche ... Unternehmens vorstellt, OneStep-1 und OneStep-2, in ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 2China Nepstar Chain Drugstore Ltd. Announces Management Change and New Director Appointment 3Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 2Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 3Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 4Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 5Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 6Dipexium kündigt eine Präsentation auf dem 7. International Symposium on the Diabetic Foot an 7
... 2011 BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) ... BMN 673, a poly ADP-ribose polymerase (PARP) inhibitor in development ... inihibtors have been validated to show survival benefits in cancer ... in combination with DNA damaging agents, and BMN 673 appears ...
... 2011 Virtual Radiologic (vRad), a technology-enabled national radiology ... the Teleradiology Services market segment by independent research and ... customer surveys and interviews conducted by KLAS and is ... in KLAS Awards: Software & Professional Services report. ...
Cached Medicine Technology:BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers 2BioMarin Initiates Phase 1/2 Trial for BMN 673 for the Treatment of Genetically-Defined Cancers 3Virtual Radiologic Ranked #1 for Teleradiology Services for Third Consecutive Year 2
(Date:5/23/2015)... With the implementation of the Affordable ... increasingly difficult to provide their employees with a viable ... insurance for employees stand to face strict penalties. Never ... part of a business’s success or failure. In an ... USA Doctors has created a varying level of less ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Center, 557 N. Washington St., Janesville, will host an ... pm. , The 8-week clinic is lead by Brent ... who will offer training that encompasses a warm-up, training ... show selection and weekly training plans. , The program ...
(Date:5/22/2015)... 22, 2015 The American College of ... in June. They will hold a webinar on the ... two-day class on Classical Chinese Medicine. , Webinar – ... Steve Given, the Dean of Clinical Education, will lead ... First Professional Doctorate program. ACTCM is currently developing this ...
(Date:5/22/2015)... Omar Ahmad Barrada, a junior at Milton ... 2015 Congress of Future Medical Leaders in Boston, Mass. ... “America’s highest achieving high school students.” , “I’m excited ... goals and learn better study habits,” said Omar. “The ... we can ask the surgeons questions.” , The goal ...
(Date:5/22/2015)... Carnegie Science Center and ... new partnership to develop BodyTech, a dynamic, three-pronged health ... includes a new exhibit at the Science Center called ... a new traveling science show, Anatomy Adventure, which will ... , Designed to explore a wide range of topics ...
Breaking Medicine News(10 mins):Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:ACTCM Announces Upcoming June Events 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4
... Provides Update on Oncology Pipeline Progress, SAN DIEGO, ... announced financial results for the three and nine,months ended ... 30,2007, the Company posted revenues of $7.6 million and ... ended September 30, 2007, revenues were $27.1,million and the ...
... Human Vaccine Against West Nile Virus Today; ... Disease Endemic in the United States, ... of sanofi-aventis Group, announced today that it has,signed an exclusive ... of a West Nile vaccine to help fight against,this serious, ...
... urinary levels of certain molecules might have the potential ... ailment caused by the autoimmune disease lupus, UT Southwestern ... a quartet of molecules may have potential diagnostic significance, ... senior author of a study available online at the ...
... CRME TSX: COM, VANCOUVER, Nov. 12 /PRNewswire-FirstCall/ - ... that it will report 2007 third,quarter financial results on ... a teleconference call and webcast at 4:30pm Eastern Time,(1:30pm ... To access the conference call, please dial 416-340-8010 ...
... Nov. 12 ,Seeking to expand Indo-U.S. healthcare ... Healthy India launched its inaugural,executive mission to ... from the,most prominent players in healthcare, including: ... Avesthagen, Excel Life Sciences,Cognizant, Stryker, BD, Yes ...
... plaguing inner-city youth at epidemic rates, the report of ... Journal of the American College of Surgeons illustrated a ... study showed that Caught in the Crossfire, a hospital-based ... system among youth aged 12 to 20. Additionally, ...
Cached Medicine News:Health News:SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007 2Health News:SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007 3Health News:SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007 4Health News:SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007 5Health News:SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007 6Health News:SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007 7Health News:SGX Pharmaceuticals Announces Financial Results for the Three and Nine Months Ended September 30, 2007 8Health News:Sanofi Pasteur and Acambis Join Forces to Bring West Nile Vaccine to Market 2Health News:Sanofi Pasteur and Acambis Join Forces to Bring West Nile Vaccine to Market 3Health News:Sanofi Pasteur and Acambis Join Forces to Bring West Nile Vaccine to Market 4Health News:Researchers investigate ways to detect lupus-associated kidney disease 2Health News:Cardiome To Release Third Quarter Results 2Health News:Cardiome To Release Third Quarter Results 3Health News:USIBC Launches Healthcare Mission to India 2Health News:Study quantifies cost-benefit of hospital-based program to keep youth out of prison 2Health News:Study quantifies cost-benefit of hospital-based program to keep youth out of prison 3
Meyerding Laminectomy Retractors, self-retaining....
Scoville-Haverfield Hemilaminectomy Retractor...
Bookwalter Spinal Retractor...
Circular Spine Retractor System for microsurgical interventions in the lumbar and cervical spine region....
Medicine Products: